Grant: Collaborative Health Research Projects
University of Saskatchewan
$75,260.00
Discovery and characterization of plant-based Phase 2 protein inducers
FY 2008-09
Summary
There is a growing body of literature indicating that phase dietary 2 protein inducing phytochemicals (P2PIs) ameliorate chronic diseases that have an underlying oxidative stress component. The quintessential example of a dietary P2PI is the isothiocyanate sulforaphane, which is found in broccoli and other cruciferous plants. However, only a limited number of dietary phase 2 protein inducers have been identified to date. The current proposal builds on an earlier pilot project whereby a number of plant extracts were screened for the ability to induce phase 2 protein gene expression, leading to the identification of both known and novel phytochemicals that function as P2PIs. Within the scope of this proposal, we intend to: 1) Produce extracts from the plants in the Canadian flora with a history of use as foods or medicines and screen them for phase 2 protein inducing activity, 2) Develop new cell-based screening assays to test for phase 1 and phase 2 protein inducing potential, 3) Isolate and identify the phytochemicals responsible for phase 2 protein inducing activities in these exstracts, and 4) Test select phase 2 inducing compounds in an animal model of chronic disease. These activities will employ novel techniques developed to rapidly screening plant extracts and delineate possible phase protein inducing phytochemcials. The most promising novel candidates will then be tested in relevant animal models of chronic disease for efficacy in ameliorating adverse events associated with hypertension, global tissue inflammation and type 2 diabetes. Achieving these objectives will improve understanding of the content of P2PIs in plants that are consumed as foods or herbal products, and potentially lead to the identification of novel bioactive phytochemicals for use in preventive medicines (e.g., as nutraceuticals and functional foods). In addition, new knowledge gained from this work may aid in the identification of new crops, validation of existing natural health products, provide for improved dietary recommendations and promote the development of the nutraceutical industry.
Program
Collaborative Health Research Projects
Recipient
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
351178-2008
Name nom
Juurlink, Bernhard
Department département
Anatomy and Cell Biology
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
75260
Program id
CHRPJ
Program nane en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
1
Nb partie
3
Application title
Discovery and characterization of plant-based Phase 2 protein inducers
Keyword
NA
Application summary
There is a growing body of literature indicating that phase dietary 2 protein inducing phytochemicals (P2PIs) ameliorate chronic diseases that have an underlying oxidative stress component. The quintessential example of a dietary P2PI is the isothiocyanate sulforaphane, which is found in broccoli and other cruciferous plants. However, only a limited number of dietary phase 2 protein inducers have been identified to date. The current proposal builds on an earlier pilot project whereby a number of plant extracts were screened for the ability to induce phase 2 protein gene expression, leading to the identification of both known and novel phytochemicals that function as P2PIs. Within the scope of this proposal, we intend to: 1) Produce extracts from the plants in the Canadian flora with a history of use as foods or medicines and screen them for phase 2 protein inducing activity, 2) Develop new cell-based screening assays to test for phase 1 and phase 2 protein inducing potential, 3) Isolate and identify the phytochemicals responsible for phase 2 protein inducing activities in these exstracts, and 4) Test select phase 2 inducing compounds in an animal model of chronic disease. These activities will employ novel techniques developed to rapidly screening plant extracts and delineate possible phase protein inducing phytochemcials. The most promising novel candidates will then be tested in relevant animal models of chronic disease for efficacy in ameliorating adverse events associated with hypertension, global tissue inflammation and type 2 diabetes. Achieving these objectives will improve understanding of the content of P2PIs in plants that are consumed as foods or herbal products, and potentially lead to the identification of novel bioactive phytochemicals for use in preventive medicines (e.g., as nutraceuticals and functional foods). In addition, new knowledge gained from this work may aid in the identification of new crops, validation of existing natural health products, provide for improved dietary recommendations and promote the development of the nutraceutical industry.